Genomtec received positive evaluation of Grant in Oncology Diagnostics from the Polish Agency for Enterprise Development (PARP) and the European Funds for a Modern Economy program

The Genomtec project, titled “Development of technology and an automatic system for mutation detection in clinical oncology based on lab-on-a-chip solutions and isothermal nucleic acid amplification techniques,” is among 198 applications positively evaluated by PARP in the SMART FENG.01.01-IP.02-001/23/2023 action within the European Funds for a Modern Economy program.